Table A6.

Descriptive statistics of acrylamide biomarker levels per study and year (children and teenagers).

Study	Pop	Year	Sample	Mean	SD	Geom. Mean	Min	Max	Median	q10	q25	q75	q90
FR-ESTEBAN	55	2014	AAMA	103.36	74.22	81.15	21.14	349.44	77.24	35.05	48.13	141.23	213.73
FR-ESTEBAN	207	2015	AAMA	115.66	130.22	89.05	11.43	1309.23	84.65	44.26	57.86	126.99	191.81
FR-ESTEBAN	37	2016	AAMA	89.47	50.36	76.88	21.67	218.46	68.104	40.81	56.70	113.32	170.74
FR-ESTEBAN	55	2014	GAMA	13.93	8.53	11.89	4.08	44.85	10.71	6.10	8.44	18.65	23.32
FR-ESTEBAN	207	2015	GAMA	15.19	11.18	13.00	2.19	110.44	12.41	7.25	9.26	17.55	22.82
FR-ESTEBAN	37	2016	GAMA	12.64	5.30	11.58	4.92	25.98	11.72	6.82	9.09	16.36	19.10
NO-NEBII	289	2016	AAMA	63.61	57.10	53.08	9.44	801.62	52.14	27.59	35.02	75.72	102.50
NO-NEBII	289	2016	GAMA	9.54	5.33	8.66	3.17	65.32	8.38	5.28	6.64	10.96	14.28
IT-EPIUD	18	2014	AAMA	58.14	49.87	42.46	12.89	224.45	47.98	14.88	19.50	78.82	97.51
IT-EPIUD	133	2015	AAMA	91.12	92.77	73.63	16.90	992.60	70.34	36.48	54.22	109.00	146.45
IT-EPIUD	149	2016	AAMA	113.47	97.86	89.71	1.46	993.34	93.98	45.61	59.59	134.95	186.04
IT-EPIUD	18	2014	GAMA	23.80	10.52	21.67	11.12	51.85	20.88	12.31	14.79	29.91	35.51
IT-EPIUD	133	2015	GAMA	34.17	16.09	30.84	8.26	97.50	31.25	18.05	22.23	41.92	55.17
IT-EPIUD	149	2016	GAMA	36.16	22.99	30.24	0.46	174.84	30.94	16.89	23.37	40.05	56.45
DE-GerES V	852	2015	AAMA	67.52	57.27	55.60	11.04	780.10	51.61	27.23	37.24	78.91	115.60
DE-GerES V	849	2016	AAMA	69.68	53.51	59.07	10.11	774.44	56.24	30.88	41.31	82.01	121.66
DE-GerES V	517	2017	AAMA	87.63	82.46	69.44	15.31	1000.00	65.51	33.94	45.79	96.95	146.11
DE-GerES V	852	2015	GAMA	13.46	8.20	11.71	2.49	89.38	11.68	6.17	8.32	16.38	22.31
DE-GerES V	849	2016	GAMA	13.27	7.37	11.72	2.42	69.67	11.47	6.42	8.31	16.06	22.77
DE-GerES V	517	2017	GAMA	18.36	12.99	15.53	5.02	147.01	15.26	7.85	10.29	22.82	30.82